FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018769689> ?p ?o ?g. }

• W2018769689 endingPage "109" @default.
• W2018769689 startingPage "101" @default.
• W2018769689 abstract "Therapeutic strategies in type 2 diabetic patients should not only integrate both the targets and indications of the different therapies but should be also a compromise between the patient's and physician's goals and willingnesses. The rationale for therapeutic targets is based on recommendations that differ from one country to another. Even though HbA1c remains the gold standard, monitoring of blood glucose at fasting and postprandial time-points is a complementary tool for estimating both the quality and safety of diabetic control. Despite the lack of available strong evidence-based data it seems that achieving glucose levels < 130 mg/dl at fasting and < 180 mg/dl or < 140 mg/dl over postbreakfast or postlunch periods, respectively, might be a reasonable goal in most countries. The choice of appropriate strategies for treating type 2 diabetic patients should ideally be based on pathophysiological considerations. However for practical reasons, decisions for initiating or completing antidiabetic treatments are usually made by using such simple parameters as HbA1c and plasma glucose levels. The bridge between pathophysiological and clinical rationales can be obtained from the analysis of the relative contributions of fasting and postprandial glucose to the overall hyperglycaemia. In patients with HbA1c < 7.3%, postprandial glucose makes the major contribution to the overall hyperglycaemia, whereas the contribution of fasting glucose becomes progressively predominant in patients with HbA1c > 7.3%. As a consequence of these observations, initiation of antidiabetic treatments or implementation of second-line therapies should be aimed at reducing either postprandial excursions or fasting hyperglycaemia according to whether HbA1c levels are found respectively below or above a cut-off value of 7.3%." @default.
• W2018769689 created "2016-06-24" @default.
• W2018769689 creator A5016980494 @default.
• W2018769689 creator A5052104436 @default.
• W2018769689 creator A5066301652 @default.
• W2018769689 creator A5080952956 @default.
• W2018769689 creator A5084778962 @default.
• W2018769689 date "2005-04-01" @default.
• W2018769689 modified "2023-09-26" @default.
• W2018769689 title "An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives" @default.
• W2018769689 cites W1527034878 @default.
• W2018769689 cites W181267088 @default.
• W2018769689 cites W1964418709 @default.
• W2018769689 cites W1967005515 @default.
• W2018769689 cites W1968676703 @default.
• W2018769689 cites W1974481324 @default.
• W2018769689 cites W1975262117 @default.
• W2018769689 cites W1976433569 @default.
• W2018769689 cites W1977119153 @default.
• W2018769689 cites W1978691530 @default.
• W2018769689 cites W1980055828 @default.
• W2018769689 cites W1989518765 @default.
• W2018769689 cites W1989874898 @default.
• W2018769689 cites W2004014076 @default.
• W2018769689 cites W2005208228 @default.
• W2018769689 cites W2008677894 @default.
• W2018769689 cites W2010760524 @default.
• W2018769689 cites W2019943219 @default.
• W2018769689 cites W2023604660 @default.
• W2018769689 cites W2026790464 @default.
• W2018769689 cites W2029749250 @default.
• W2018769689 cites W2032912656 @default.
• W2018769689 cites W2033125833 @default.
• W2018769689 cites W2040864865 @default.
• W2018769689 cites W2043595549 @default.
• W2018769689 cites W2044289556 @default.
• W2018769689 cites W2052700434 @default.
• W2018769689 cites W2056319298 @default.
• W2018769689 cites W2063018178 @default.
• W2018769689 cites W2063423309 @default.
• W2018769689 cites W2072365328 @default.
• W2018769689 cites W2074366941 @default.
• W2018769689 cites W2077631943 @default.
• W2018769689 cites W2077702349 @default.
• W2018769689 cites W2077971957 @default.
• W2018769689 cites W2081136047 @default.
• W2018769689 cites W2084772097 @default.
• W2018769689 cites W2086438882 @default.
• W2018769689 cites W2090609048 @default.
• W2018769689 cites W2092653445 @default.
• W2018769689 cites W2110590807 @default.
• W2018769689 cites W2123744385 @default.
• W2018769689 cites W2123970128 @default.
• W2018769689 cites W2126781806 @default.
• W2018769689 cites W2128285501 @default.
• W2018769689 cites W2129512027 @default.
• W2018769689 cites W2129514415 @default.
• W2018769689 cites W2139634859 @default.
• W2018769689 cites W2160234571 @default.
• W2018769689 cites W2161743236 @default.
• W2018769689 cites W2162831008 @default.
• W2018769689 cites W2164733897 @default.
• W2018769689 cites W2170502600 @default.
• W2018769689 cites W2332951586 @default.
• W2018769689 cites W2334539242 @default.
• W2018769689 cites W2337454357 @default.
• W2018769689 cites W3109617681 @default.
• W2018769689 cites W4213243604 @default.
• W2018769689 cites W4234147305 @default.
• W2018769689 cites W4245063811 @default.
• W2018769689 cites W4249862680 @default.
• W2018769689 cites W4252168224 @default.
• W2018769689 doi "https://doi.org/10.1016/s1262-3636(07)70174-x" @default.
• W2018769689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15959415" @default.
• W2018769689 hasPublicationYear "2005" @default.
• W2018769689 type Work @default.
• W2018769689 sameAs 2018769689 @default.
• W2018769689 citedByCount "33" @default.
• W2018769689 countsByYear W20187696892013 @default.
• W2018769689 countsByYear W20187696892014 @default.
• W2018769689 countsByYear W20187696892015 @default.
• W2018769689 countsByYear W20187696892016 @default.
• W2018769689 countsByYear W20187696892017 @default.
• W2018769689 countsByYear W20187696892018 @default.
• W2018769689 countsByYear W20187696892019 @default.
• W2018769689 countsByYear W20187696892020 @default.
• W2018769689 countsByYear W20187696892021 @default.
• W2018769689 crossrefType "journal-article" @default.
• W2018769689 hasAuthorship W2018769689A5016980494 @default.
• W2018769689 hasAuthorship W2018769689A5052104436 @default.
• W2018769689 hasAuthorship W2018769689A5066301652 @default.
• W2018769689 hasAuthorship W2018769689A5080952956 @default.
• W2018769689 hasAuthorship W2018769689A5084778962 @default.
• W2018769689 hasConcept C126322002 @default.
• W2018769689 hasConcept C134018914 @default.
• W2018769689 hasConcept C177713679 @default.
• W2018769689 hasConcept C2777180221 @default.
• W2018769689 hasConcept C2778199505 @default.

• next